Omeros (OMER) Depreciation and Depletion (2023 - 2026)
Omeros recorded quarterly Depreciation and Depletion of $200000.0 in Q1 2026, little changed quarter-over-quarter from $200000.0 in Q3 2025, and down 33.33% year-over-year from $300000.0 in Q1 2025.
Omeros' Depreciation and Depletion history runs 4 years deep, the most recent figure standing at $200000.0 for Q1 2026.
- In Q1 2026, Depreciation and Depletion fell 33.33% year-over-year to $200000.0; the TTM figure through Mar 2026 stood at $900000.0 (changed 0.0% YoY), while the FY2014 annual figure was $326000.0, up 7.95% from the prior year.
- Depreciation and Depletion came in at $200000.0 for Q1 2026 at Omeros, roughly flat from $200000.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $300000.0 in Q2 2023 to a low of $200000.0 in Q1 2023.
- A 4-year average of $220000.0 and a median of $200000.0 in 2023 frame the typical range for Depreciation and Depletion.
- Across the five-year window, Depreciation and Depletion tumbled 33.33% in 2024 and surged 50.0% in 2025, its largest moves.
- Omeros' Depreciation and Depletion stood at $200000.0 in 2023, then changed by 0.0% to $200000.0 in 2024, then changed by 0.0% to $200000.0 in 2025, then changed by 0.0% to $200000.0 in 2026.
- According to Business Quant data, Depreciation and Depletion over the past three periods registered $200000.0, $200000.0, and $200000.0 for Q1 2026, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn | 200,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 200,000.00 |
| Mar 31, 2026 | 200,000.00 |
| Sep 30, 2025 | 200,000.00 |
| Sep 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Mar 31, 2025 | 300,000.00 |
| Mar 31, 2025 | 300,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 200,000.00 |
| Mar 31, 2024 | 200,000.00 |
| Mar 31, 2024 | 200,000.00 |
| Sep 30, 2023 | 200,000.00 |
| Sep 30, 2023 | 200,000.00 |
| Jun 30, 2023 | 300,000.00 |
| Jun 30, 2023 | 300,000.00 |
| Mar 31, 2023 | 200,000.00 |
| Mar 31, 2023 | 200,000.00 |